Raltegravir

• Target:

  HIV Protease|||Integrase

• Related Pathways:

  Microbiology/Virology|||Proteases/Proteasome

• Purity:

  >99.99%

• Bioactivity:

  Raltegravir (MK-0518) is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.

• Smiles:

  Cc1nnc (o1) C (=O) NC (C) (C) c1nc (C (=O) NCc2ccc (F) cc2) c (O) c (=O) n1C

• Molecular Formula:

  C20H21FN6O5

• Molecular Weight:

  444.42

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  518048-05-0